Retina news: What's hot (and not)

Video
Conference|SECO

Mohammad Rafieetary, OD, FAAO, offers a sneak peek at the latest (and fake!) news in retina.

During SECO 2022, Mohammad Rafieetary, OD, FAAO, consultative optometric physician at the Charles Retina Institute in Germantown, Tennessee, offers Optometry Times®' Alex Delaney-Gesing a sneak peek at the latest news in retina— including for diabetic retinopathy and age-related macular degeneration (AMD) —as well as common "fake news" circualting in medicine as a whole.

See more conference coverage

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Rachelle Lin, OD, MS, FAAO
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Related Content
FDA accepts sBLA for Eylea HD for priority review by FDA - Image credit: ©Milos—stock.adobe.com

Regeneron’s sBLA for Eylea HD accepted for priority review by FDA

Martin David Harp, Editor, Ophthalmology Times
April 17th 2025
Article
Optometry Times You and Eye

You and Eye: What optometrists need to know about low vision

Miriam Korik, OD;Emily Kaiser Maharjan, Assistant Managing Editor
March 13th 2024
Podcast
FDA accepts updated BLA from Outlook Therapeutics for ONS-5019 for wet AMD - Image credit: Adobe Stock / ©Have a nice day

FDA accepts updated biologics license application from Outlook Therapeutics for ONS-5010 for the treatment of wet AMD

Martin David Harp, Editor, Ophthalmology Times
April 9th 2025
Article
Advances in treatment for geographic atrophy

Advances in treatment for geographic atrophy

David S. Boyer, MD;Tina Mac Donald, OD, CDCES, FAAO;Leo P. Semes, OD, FAAO
October 11th 2023
Podcast
Syphilis pathogen Image credit: AdobeStock/ChristophBurgstedt

Timely diagnosis and management of ocular syphilis to prevent permanent visual loss

Lynda Charters
April 4th 2025
Article
Opthea discontinues COAST and ShORe clinical trials for wet AMD - Image credit: Adobe Stock / ©Phimwilai

Opthea discontinues COAST and ShORe trials in wet AMD

Martin David Harp, Editor, Ophthalmology Times
March 31st 2025
Article
© 2025 MJH Life Sciences

All rights reserved.